Captor Therapeutics Spolka Akcyjna

WSE:CTX.WA

105 (PLN) • At close December 14, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) PLN.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q3
Omzet 2.9543.534.8364.5056.4852.8142.3591.5435.8211.111.1911.0361.2791.2531.030.42400
Kosten van de omzet 2.1471.1261.4031.5214.9931.76-0.1620.4330.9580.5440.3030.2820.2590.4820000.007
Brutowinst 0.8072.4043.4332.9841.4921.0542.5211.114.8630.5660.8880.7541.020.7711.030.4240-0.007
Brutowinstmarge 0.2730.6810.710.6620.230.3751.0690.7190.8350.510.7460.7280.7970.6151100
Onderzoek- en ontwikkelingskosten 7.52410.3169.22310.00614.09915.38421.44413.4523.4485.9048.2996.5046.4756.455.4894.7024.6916.302
Algemene en administratieve kosten 02.4043.3422.6082.6415.0984.0944.3042.5085.6155.3946.0415.3655.7774.6343.7691.2161.689
Verkoop- en marketingkosten 00001.3910000000000000
Verkoop-, algemene en administratieve kosten 4.2642.4043.3422.6084.0325.0984.0944.3042.5085.6155.3946.0415.3655.7774.6343.7691.2161.689
Overige kosten 000.990000-1.188-12.899-1.633-2.808-0.938-0.01-1.557-3.308-2.833-4.409-1.76
Bedrijfskosten 11.78812.74113.55512.70618.13117.32132.24216.56613.0579.88610.88511.60711.8310.676.8155.6381.4986.231
Bedrijfsresultaat -10.981-10.337-10.122-9.722-16.639-16.267-29.72-15.456-8.194-9.32-9.997-10.853-10.811-8.768-6.916-5.214-1.498-6.231
Bedrijfsresultaat ratio -3.717-2.928-2.093-2.158-2.566-5.781-12.599-10.017-1.408-8.396-8.394-10.476-8.453-6.998-6.715-12.29700
Totaal overige inkomsten en kosten netto 2.2210.0950.1380.2820.0860.4920.6841.2271.6790.7810.133-0.123-0.091-0.102-0.557-0.114-0.095-0.08
Inkomen voor belasting -8.76-10.242-9.984-9.44-11.486-15.775-29.036-14.23-6.515-8.539-9.864-10.976-10.902-8.87-7.473-5.328-1.593-6.311
Inkomen voor belasting ratio -2.965-2.901-2.065-2.095-1.771-5.606-12.309-9.222-1.119-7.693-8.282-10.595-8.524-7.079-7.255-12.56600
Belastingkosten 0000.3411.0920.5570.057-1.226-1.679-0.781-0.1330.1230.076-1.1470.713-0.0150.004-0.012
Nettowinst -8.76-10.242-9.984-9.44-11.486-15.775-29.093-13.004-4.836-7.758-9.731-11.099-10.902-8.87-7.474-5.327-1.593-6.311
Nettowinstmarge -2.965-2.901-2.065-2.095-1.771-5.606-12.333-8.428-0.831-6.989-8.17-10.713-8.524-7.079-7.256-12.56400
WPA (Winst Per Aandeel) -1.59-2.19-2.14-2.04-2.47-3.72-6.91-3.09-1.16-1.86-2.36-2.69-2.64-2.15-1.81-1.64-0.49-1.94
Verwaterde WPA -1.59-2.2-2.14-2.04-2.47-3.72-6.91-3.09-1.16-1.85-2.36-2.69-2.64-2.15-1.81-1.64-0.49-1.94
EBITDA -7.512-8.646-8.536-8.235-10.276-14.494-27.629-12.527-6.588-6.841-7.869-8.954-9.011-8.057-6.547-3.4070.349-6.236
EBITDA ratio -2.543-2.449-1.765-1.828-1.585-5.151-11.712-8.119-1.132-6.163-6.607-8.643-7.045-6.43-6.356-8.03500